Advertisement
Canada markets open in 4 hours 18 minutes
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7327
    +0.0004 (+0.05%)
     
  • CRUDE OIL

    83.70
    +0.13 (+0.16%)
     
  • Bitcoin CAD

    87,976.74
    +467.48 (+0.53%)
     
  • CMC Crypto 200

    1,388.95
    -7.59 (-0.54%)
     
  • GOLD FUTURES

    2,360.10
    +17.60 (+0.75%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,731.50
    +164.00 (+0.93%)
     
  • VOLATILITY

    15.58
    +0.21 (+1.37%)
     
  • FTSE

    8,106.13
    +27.27 (+0.34%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6819
    -0.0002 (-0.03%)
     

Why STAAR Surgical Stock Is Triumphant Today

STAAR Surgical (NASDAQ: STAA) stock was up by 16% as of 3:36 p.m. ET on Thursday after it smashed the market's expectations for its second-quarter earnings, reporting net sales of $81.1 million and $0.26 in net income per diluted share. The strong sales in China and India indicate that STAAR's ongoing push into major international vision correction markets is going swimmingly. Right now, its market share in China is estimated to be above 20%, which bodes well for its future performance there.